financingNew partnerships push InDevR for Series B... InDevR Inc., a provider of analytical technologies for vaccines and biotherapeutics, has raised $9m in Series B financing. more ➔
fundingVésale Bioscience wins R&D grant Phage therapy specialist Vésale Bioscience gas bageds €1.8m from European Innovation Council (EIC) to fight antibiotic resistance (AMR). more ➔
Abionyx Pharma announces success in fighti...Abionyx Pharma SA has announced positive data from Phase IIa testing of iCER-001, a recombinant apoA-I, as a treatment for septic patients at high risk of developing Acute Kidney Injury (AKI) … more ➔
M&ABioNTech bags Instadeep for £562mBioNTech SE will pay £562m in cash to acquire its former partner InstaDeep Ltd. to expand its capabilities in AI-based drug discovery. more ➔
ApprovalRoche withdraws checkpoint blocker from th...Roche AGs US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market after disappointing results in bladder cancer. more ➔
Novo Holdings invests into standardisation...Evosep APS has inked a $40m funding deal with Novo Holdings A/S that is aimed to advance standardised clinical LC-MS-based drug discovery and diagnostic multi-marker tests. more ➔
financingExeVir receives EIB risk finance for multi...With the help of a €25m loan from the European Investment Bank, ExeVir BIO BV will advance clinical trials with its COVID-19 nanobody XVR012. more ➔
partnershipHummingbird and Synaffix in $150m ADC dealRational antibody design specialist Hummingbird Bioscience has licenced a cancer target and the modular ADC technology of Dutch Synaffix BV. more ➔
partnershipEthris inks €15m deal with Indian CiplasCipla EU Ltd is going to make an equity investment of €15m in Ethris GmbH, a specialist for respiratory delivery of therapeutic mRNAs. more ➔
MSFirst hints for leukopenia diagnostic in M...Scientists from the University of Basel and the University Hospital Basel have found that two bacterial species may indicate multiple sclerosis-associated lymphopenia. more ➔
